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A B S T R A C T
Maternal prenatal cortisol levels have been inconsistently associated with self-reports of prenatal psychological
distress (PD). Previous research has linked hair cortisol concentration (HCC) evaluating cumulatively the pre-
vious months with cross-sectional PD measures that usually cover the past week(s), which may lead to mis-
leading conclusions on their relations. We aimed to investigate how maternal HCC relates to cumulative PD
measures across pregnancy.
Methods: Subjects (N= 595) were drawn from the FinnBrain Birth Cohort Study. Maternal HCC was measured
from hair samples collected at gestational week (gwk) 24 (HCC1, n=467) and at delivery (HCC2, n= 222). As
HCC1 and HCC2 comprised mostly of different subjects, they were considered as independent populations.
Maternal PD assessments at gwks 14, 24, and 34 were the Edinburgh Postnatal Depression Scale (EPDS), the
anxiety subscale of the Symptom Checklist (SCL-90), the Pregnancy-Related Anxiety Questionnaire -Revised2
(PRAQ-R2), and a daily hassles scale. Cumulative PD comprised of the mean scores of two consecutive assess-
ments (mean1 = gwks 14 and 24; mean2 = gwks 24 and 34). In addition, EPDS and SCL scores were modelled
by using growth mixture modelling to identify symptom trajectory categories. Regression models were adjusted
for age, body mass index, education and use of selective serotonin/serotonin-norepinephrine reuptake inhibitor
medication.
Results: In the adjusted regression model, higher HCC2 was related to the “consistently elevated” prenatal de-
pressive symptoms trajectory in comparison to “consistently low” (β =.71, p=.021) and “low and increasing”
(β =.82, p= .011) symptom trajectories. Additionally, the cumulative mean (mean 1) of daily hassles in re-
lationships was associated with HCC1 (β=0.25, p= .004). General or pregnancy-related anxiety symptoms
were unrelated to HCC after adjustment for the covariates.
Conclusions: The assessment of cumulative or trajectory measures of PD can reveal important associations with
maternal prenatal HCC, even though the associations are generally weak. Of the different dimensions of PD,
prenatal trajectories of depressive symptoms were most consistently linked with end-pregnancy HCC levels.
1. Introduction
Maternal prenatal psychological distress (PD) is associated with
offspring development and health outcomes (O’Donnell and Meaney,
2017; van den Bergh et al., 2017) as well as with altered offspring brain
structure, function and connectivity (van den Bergh et al., 2018). Fetal
exposure to altered maternal cortisol levels is considered to be one of
the major mediators of these effects (Entringer et al., 2015; Rakers
et al., 2017), while data linking maternal prenatal cortisol concentra-
tions with both maternal symptoms of prenatal PD and different child
outcomes are inconsistent (Seth et al., 2016; Zijlmans et al., 2015). One
possible reason for this incongruence is the methodological mismatch
when short-term measurements, such as salivary or plasma cortisol, are
used to reflect longer term cortisol homeostasis (Cherak et al., 2018;
Seth et al., 2016; Zijlmans et al., 2015).
Hair cortisol concentration (HCC) as a marker of long-term cortisol
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secretion has been presented as a solution to mitigate this challenge and
thus far, there are nine studies assessing the associations between
prenatal PD and HCC (Bowers et al., 2018; Duffy et al., 2018; Orta et al.,
2018; for a review, see Mustonen et al., 2018). However, the existing
research yields rather inconsistent information on the associations be-
tween self-reported symptoms of PD and HCC, and only three of the
nine studies have found HCC to be associated with some type of PD
(Hoffman et al., 2016; Kalra et al., 2007; Orta et al., 2018).
Several factors can affect functioning of the hypothalamic-pituitary-
adrenal (HPA) axis and not all symptoms of prenatal PD are likely to be
associated with increased long-term cortisol levels. The type, levels,
duration and timing of prenatal PD most likely matter. On the other
hand, utilizing HCC poses a novel challenge regarding temporal dy-
namics, as we are measuring cortisol exposure over several months with
HCC, while PD questionnaires often assess distress symptoms during the
previous days or weeks (Braig et al., 2015b; Scharlau et al., 2017).
One way to overcome these methodological issues is to analyze the
PD symptom trajectories across time. The mean scores of several
timepoints can be used as a crude estimate of cumulative stress over
time, and a more fine-tuned version is to utilize latent growth mixture
modelingmodelling (Muthén and Muthén, 2000) to identify distinct
groups with different trajectories of self-reports of PD (e.g., Korja et al.,
2018). According to our knowledge, however, no previous studies in
pregnant or non-pregnant populations have assessed the associations
between HCC and PD trajectories reflecting the longitudinal course of
PD. Additionally, very few have utilized cumulative scores of repetitive
measures of PD (Scharlau et al., 2017).
Of note, cortisol levels increase normally up to 2–3-fold towards the
end of pregnancy, largely because placental corticotropin-releasing
hormone (CRH) secretion is enhanced by a positive feedback loop of the
HPA axis (Jung et al., 2011). Additionally, the efficacy of placental 11β-
HSD2 enzyme functioning in converting cortisol into its inactive me-
tabolites is significant in protecting the fetus from excessive levels of
maternal cortisol (Reynolds, 2013). Importantly, the 11β-HSD2 activity
can be diminished by PD (Janssen et al., 2016). In addition to the
overall cortisol levels rising towards the end of pregnancy, the re-
activity of the HPA axis functioning attenuates during the last trimester
(de Weerth and Buitelaar, 2005; Howland et al., 2017). As these nor-
mative physiological changes occur in cortisol secretion towards the
end of pregnancy, cross-sectional measures of PD have limitations in
explaining the variance in end-of-pregnancy HCC. In line with this,
previous research reports associations between PD symptoms and HCC
only in mid-pregnancy assessments (Hoffman et al., 2016; Kalra et al.,
2007; Orta et al., 2018) and not when HCC has been measured post-
partum (Braig et al., 2015b; Duffy et al., 2018).
The aim of this study was to assess the associations between ma-
ternal prenatal HCC and different types and timelines of maternal
prenatal PD symptoms. First, we examined cross-sectional associations
between recent PD measures and HCC measured at the same time.
Second, we assessed cumulative PD as the mean of two consecutive PD
measures to better match the timeline the HCC measures reflect. Third,
we identified distinct trajectories of depressive and anxiety symptoms
throughout pregnancy. PD was measured longitudinally throughout the
pregnancy by repeated assessments. HCC was measured cross-section-
ally in mid- and the end of pregnancy from two largely distinct study
populations. We first hypothesized that cumulative PD measures and
trajectories of PD symptoms across pregnancy are predictors of ma-
ternal HCC. Second, if associations with cross-sectional (recent or cu-
mulative) PD symptoms would be seen, we expected them to be more
pronounced in mid-pregnancy than in the end of pregnancy. Third, we




The study subjects were drawn from the FinnBrain Birth Cohort
Fig. 1. Flow chart of the study design.
Notes of abbreviations: PD = psychological distress; EPDS = the Edinburgh Postnatal Depression Scale; SCL-90 = the Symptom Checklist −90; PRAQ-R2 = the
Pregnancy-related Anxiety Questionnaire -Revised2; gwk = gestational week; HCC1 = hair cortisol concentration measured at gwk 24; HCC2 = hair cortisol
concentration measured 1–3 days after delivery.
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Study, a population-based longitudinal pregnancy cohort (www.
finnbrain.fi; Karlsson et al., 2018). Consecutive pregnant women at-
tending a routine ultrasound at the gestational week (gwk) 12 were
recruited to the study between December 2011 and April 2015 at three
sites in Turku, Finland and the Åland Islands, Finland. Parent(s) parti-
cipating in the study gave their written informed consent. The number
of women recruited in the whole cohort was 3808. The participation
rate was 66% of those informed about the project. The attrition rate
during pregnancy was 8.1% (Karlsson et al., 2018).
This study was carried out with a sub-population of women who
donated hair samples at second trimester (gwk 24) study visits (ex-
cluded if gwks at sample taking were< 21 or>28, N=2 and 35,
respectively) and/or at the delivery ward 1–3 days after giving birth
(excluded if gwks< 34, N=0) (Fig. 1). The overall participation rate
for the gwk 24 study visit was approximately 44% of all the 3808
mothers in the Cohort (Karlsson et al., 2018). Collection of gwk 24 hair
samples begun at March 2013, after which hair samples were collected
from consecutive Cohort subjects who gave their consent and had
adequately hair for sample collection. The collection of gwk 40 hair
samples began in December 2014.
2.2. Measures
2.2.1. Hcc
Maternal hair samples were collected at gwk 24 (hereafter HCC1)
and after delivery (hereafter HCC2). A strand of hair at least 5 cm long
was cut from a standardized area of the posterior vertex region of the
head as close to the scalp as possible (Greff et al., 2018; Sauvé et al.,
2007). Hair samples were stored in foil in a dry place protected from
light according to good research practise, Finnish legislation and data
protection until the analyses. The analyses were performed at Life and
Health Sciences Research Institute (ICVS), University of Minho, Por-
tugal. For the analysis, a 5 cm segment was cut from samples with
adequate length to cover the past 5 months [based on an estimate of
1 cm growth per month (Greff et al., 2018)]; and 5–15mg of each
sample was analysed.
The hair segments were washed in isopropanol for 3min three times
and finely minced using surgical scissors. For extraction of cortisol,
1.5 ml of methanol was added to each sample and the samples were
incubated at 55 °C for 24 h. After centrifuging at 10,000 rpm for 2min,
the supernatant was transferred to a new vial. Methanol was evaporated
at 60 °C under a constant stream of nitrogen until samples were dried
completely. Finally, 0.15ml of phosphate buffer was added and 50 μl of
each sample was analysed with ELISA (IBL International Cortisol Saliva
ELISA) following the manufacturer’s procedure. All samples were ana-
lysed in duplicates and the mean intra-assay coefficients of variation for
HCC1 was 3.2% (SD 3.1, range 0.00–14.9 %). For HCC2, the mean
coefficient of variation was 2.8% (SD 2.5, range 0.00–12.5 %).
In total, N=953 maternal hair samples were collected at gwk 24
study visits (82% of the mothers from the beginning of the hair sample
collection). For the gwk 40 sample collection, 296 mothers were con-
tacted personally at the delivery ward with 91% of them (N=270)
donating a hair sample. The exclusion of samples outside the weight
range of 5–15mg (HCC1 n=441 samples excluded, HCC2 n=43
samples excluded) was based on sensitivity analyses suggesting that
both very low and very high sample weights were related to increased
sample weight -related HCC variance. Final numbers after all exclusions
were: N=467 samples for HCC1 and N=222 for HCC2 (Fig. 1). Of the
467 participants in HCC1 population, 20.1% (94 subjects) were also
included in HCC2. Still, as the HCC1 and HCC2 populations comprised
mostly different subjects, they were treated as independent samples and
the trajectory approach was not applied to HCC measures.
2.2.2. Prenatal PD measures
Prenatal psychological distress was measured by using several
standardized self-report research questionnaires that assess different
subtypes of PD. Questionnaires assessing depressive, anxiety and
pregnancy-related anxiety symptoms and stressfulness of daily experi-
ences were sent to subjects repeatedly at three assessment points during
pregnancy; at gestational weeks 14, 24, and 34. The research ques-
tionnaires were either mailed to the subjects or they could be filled in
online. Depressive symptoms were assessed with the Edinburgh
Postnatal Depression Scale (EPDS; Cox et al., 1987), general anxiety
symptoms with the Symptom Checklist −90, anxiety subscale (SCL-90;
Derogatis et al., 1973; Holi et al., 1998), pregnancy-specific anxiety
with the Pregnancy-Related Anxiety Questionnaire –Revised (PRAQ-R2;
Huizink et al., 2016, 2004), and the stressfulness of daily experiences
with the modified Daily Hassles scale (Korpela et al., 2008). The time
spans that the questionnaires assess are one week for EPDS, one month
for SCL-90 and three months for Daily Hassles. The instructions of
PRAQ-R2 do not specify the time span but ask the subject to rate “what
best describes your situation”. The Cronbach α values for EPDS, SCL-90
and PRAQ-R2 at gwks 14, 24, and 34 were between 0.82–0.86. Stressful
daily life experiences were assessed with three separate items from the
Daily Hassles scale [hassles related to social relationships (DH1), work
(DH2), and money (DH3)] each rated on a four-point Likert-scale on
how much concerns the hassles induced in daily life.
The continuous total sum scores for EPDS, SCL-90, and PRAQ-R2
were utilized. Missing values of individual items were imputed with the
mean of the other item responses of the study subject, with a maximum
of 1/3 of missing responses/questionnaire being acceptable for being
included in the data set. As HCC was estimated to measure long-term
cortisol levels during the previous 5 months, the means of questionnaire
sum scores of the previous two timepoints [(gwks 14+24) / 2 =
mean1 and (gwks 24+ 34) / 2 = mean2] were calculated to corre-
spond with HCC24 and HCC40, respectively, to assess cumulative
scores of the self-reported PD symptoms. As the questionnaires assess
PD symptoms from one week to three months, the time span depicted
by the mean of two questionnaires assessed ten weeks apart from each
other varies from approximately 2.5 months to 5 months. Means were
calculated only when data from both timepoints were available for each
questionnaire, which affected particularly PRAQ-R2 values, where the
questionnaire was added in the gwk 14 questionnaires only in June
2014 (NPRAQ gwk14 =333, NPRAQ gwk24 =615, and NPRAQ gwk34 =573).
In addition, Latent Growth Mixture Modelling (LGMM; Muthén and
Muthén, 2000) was utilized to model the trajectories of maternal pre-
natal symptoms of depression and general anxiety (the EPDS and SCL-
90, respectively; for details see paragraph 2.3) as these symptoms were
assessed three times during pregnancy among the whole sample with
questionnaires with eligible psychometric properties thus enabling their
modelling with LGMM.
2.2.3. Covariates
Several potential maternal and hair-related covariates were selected
based on prior research (Braig et al., 2015a; Stalder et al., 2017). Data
on potential covariates were available from questionnaires (gwks 14
and 34) and from the Finnish Medical Birth Register administered by
the National Institute of Health and Welfare (www.thl.fi) (Table 1).
Data on maternal age (years) at delivery (categorized as< 25,
25–35 and>35), pre-pregnancy body mass index (BMI, kg/m2; cate-
gorized as ≤ 20, 20,01–25, 25,01–30 and> 30), smoking during
pregnancy (0 = “not at all”, 1 = “yes, before knowing about the
pregnancy”, 2 = “yes, smoking throughout pregnancy”), sex of the
child (girl/boy), and gestational weeks at delivery were drawn from the
Finnish Medical Birth Register.
Self-report questionnaires were used to obtain information on other
covariates including maternal educational level [categorized as “Low”
(high school/vocational, < 12 years), “Medium” (polytechnics), or
“High” (university degree or comparable], parity (dichotomized as
primiparous vs others), marital status (dichotomized as married/do-
mestic partnership vs others), ethnicity (dichotomized as Caucasian vs
others), use of medications [assessed at gwk 14 for the HCC1 group and
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gwk 34 for the HCC2 group; selective serotonin (and noradrenalin)
reuptake inhibitors (SSRI/SNRI; yes/no), inhaled/topical corticoster-
oids (yes/no), systemic anti-inflammatory drugs (yes/no)], substance
use during the index pregnancy [based on both gwk 14 and 34 ques-
tionnaires; alcohol (0 = “not at all”, 1 = “yes, before knowing about
the pregnancy” and 2 = “yes”) and illicit drugs (yes/no)]. The hair-
related attributes that were considered were hair color (blond/dark),
hair dying (yes/no), frequency of hair washing (more or less frequently
than 4 times per week), and the season of sample taking (“Winter” from
December to February, “Spring” from March to May, “Summer” from
June to August, and “Autumn” from September to November) (Braig
et al., 2015a).
2.3. Statistical analyses
The HCC data were examined for outliers and values> 3 standard
deviations (SD) above the mean were excluded from the final analyses
(N= 8 for HCC1 and N=5 for HCC2; Stalder et al., 2013). According
to common practise, natural logarithmic transformations were per-
formed on the HCC data to reduce skewness. However, raw con-
centration values are provided when presenting the mean values of HCC
(see Tables 1 and 4). All the analyses were performed separately for
HCC1 and HCC2 as they comprised different populations. We first
tested the correlations between HCC and different PD measures to select
which PD measures to include as independent variables in the adjusted
models. For those with suggestive of statistically significant associations
(p < 0.1), we then carried on to the adjusted models. Based on lit-
erature on possible biological relevance (Braig et al., 2015a; Stalder
et al., 2017) and statistical associations between the potential con-
founders with both HCC and PD, the covariates were included in the
models in a stepwise manner. The first step (Model1) was adjusted for
maternal education, age and BMI. In the second step (Model 2), ma-
ternal use of SSRI/SNRI medication was added as a covariate. Analysis
of covariance (ANCOVA) was used in the modelling.
In addition to the confounders selected in the final models, HCC was
also associated with seasonality, marital status, use of systemic anti-
inflammatory drugs and use of illicit drugs. However, as these factors
were unrelated to PD measures, they were not included in the final
models. Further, sensitivity analyses excluding subjects reporting the
use of anti-inflammatory or illicit drugs did not alter the results on the
relations between PD and HCC1/2, thus these subjects were retained in
the data analyses.
To be able to assess the influence of attrition, the subjects were
compared with both 1) all Cohort participants and 2) those who had
provided a hair sample but whose sample was excluded from the ana-
lyses: no differences in any of the PD measures were noted (see
Appendix A). Moreover, no differences in any of the covariates were
noted between the latter group and the final study population
(Appendix A). Comparison with the whole Cohort population revealed
that subjects not providing hair samples were younger [mean age 30.1
(SD 4.8) vs 30.9 (SD 4.4) years, respectively, p > 0.001], less educated
(vocational 40.0% vs 28.1%, polytechnics 27.9% vs 33.6% and uni-
versity level 32.0% vs 38.3%, respectively, p > 0.001), and reported
Table 1
Descriptives and confounding factors.
HCC1 (N=467) HCC2 (N=222)
mean (SD) / N (%) mean (SD) / N (%)
Maternal covariates
Age at delivery (years) 31.1 (4.3) 30.6 (4.2)
Age in 3 categories
< 25 27 (5.8) 16 (7.2)
25–35 324 (69.4) 162 (73.0)
> 35 116 (24.8) 44 (19.8)
BMI before pregnancy (kg/m2) 24.5 (4.4) 24.5 (4.8)
BMI in 4 categories
≤20 37 (7.9) 18 (8.1)
20,01 - 25 269 (57.6) 126 (56.8)
25,01 - 30 114 (24.4) 53 (23.9)
> 30 42 (9.0) 21 (9.5)
Education
High school / vocational
(< 12years)
107 (22.9) 63 (28.4)
Polytechnics 162 (34.7) 61 (27.5)
University 178 (38.1) 81 (36.5)
Parity
Nulliparous 261 (55.9) 134 (60.4)
Others 184 (39.4) 72 (32.4)
Marital status
Married/domestic partnership 414 (89.5) 186 (83.8)
Others 26 (5.6) 16 (7.2)
Ethnicity




No 421 (90.1) 167 (75.2)
Yes 20 (4.3) 3 (1.8)
Inhaled/topical corticosteroids
No 420 (89.9) 162 (73.0)
Yes 21 (4.5) 8 (3.6)
Systemic anti-inflammatory drugs
No 435 (93.1) 169 (76.1)
Yes 6 (1.3) 0 (0)
Substance use
Alcohol
No 330 (70.7) 151 (68.0)
Yes, before knowing about pregnancy 59 (12.6) 31 (14.0)
Yesa 51 (10.9) 16 (7.2)
Smoking
No 419 (89.7) 196 (88.3)
Yes, before knowing about pregnancy 33 (7.1) 15 (6.8)
Yes 9 (1.9) 7 (3.2)
Drugs
No 436 (93.4) 195 (87.8)
Yes 2 (0.4) 4 (1.8)
Gender of the fetus
Girl 235 (50.3) 102 (45.9)
Boy 231 (49.5) 119 (53.6)
Gestational weeks at delivery 39.6 (1.9) 39.7 (1.4)
Hair and hair sample related
attributes
Gestational weeks at sample taking 24.5 (1.0) 39.9 (1.4)
Season at sample taking
Spring 142 (30.4) 58 (26.1)
Summer 123 (26.3) 57 (25.7)
Autumn 119 (25.5) 22 (9.9)
Winter 83 (17.8) 85 (38.3)
Hair color
Blond 173 (37.0) 98 (44.1)
Dark 282 (60.4) 123 (58.7)
Hair washing
< 4 times /week 330 (70.7) 165 (74.3)
> 4 times /week 127 (27.2) 56 (25.2)
Hair dying
No 88 (18.8) 59 (26.6)
Yes 379 (81.2) 162 (73.0)
Sample weight (mg) 9.9 (3.1) 11.2 (3.3)
Table 1 (continued)
HCC1 (N=467) HCC2 (N=222)
mean (SD) / N (%) mean (SD) / N (%)
Hair cortisol concentration (pg/mg) 19.8 (34.6) 20.5 (19.9)
Notes of abbreviation: HCC1 = hair cortisol concentration measured at gesta-
tional week 24; HCC2 = hair cortisol concentration measured 1–3 days after
delivery; BMI=body mass index.
a 70% of subjects with continuous alcohol use during pregnancy reported
using alcohol less than monthly and for 52%, the amount was less than 0.5 units
per time.
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the use of SSRI/SNRIs in the end of pregnancy less frequently (2.3% vs
4.1%, p= .026) than the subjects in the final HCC1/2 populations
(Appendix A).
LGMM was used to model the trajectories of depressive and general
anxiety symptoms from gwk 14 to gwk 34. Pregnancy-related anxiety
symptoms could not be modelled with LGMM as the number of subjects
with all three measures was too low. The psychometric properties of
Daily Hassles scale precluded its inclusion in this type of modelling.
Growth curves of symptoms were estimated for each individual, sepa-
rately for each symptom category, and then prototypic curves were
identified for the whole sample. The aim was to select latent curves, i.e.,
the developmental patterns in symptoms that most optimally describe
the data and are also interpretable. Individual item scores were used in
the models, and participants with missing data were incorporated in the
analyses with maximum likelihood under the missing-at-random as-
sumption (Graham, 2009), in order to minimize bias (Nagin, 2005).
LGMM was performed among subjects with both PD questionnaire data
and the relevant HCC1 or HCC2 measurement.
First, the factor structures of prenatal PD questionnaires were ex-
amined separately for depressive and anxiety symptoms using struc-
tural equation modelling. The longitudinal Confirmatory Factor
Analysis of the EPDS and SCL-90 showed good fit with the data (see
Appendix B).
In the LGMM, the numbers of maternal prenatal PD latent classes,
separately for EPDS and SCL-90 scores, were determined by increasing
the number of classes in separate analyses and observing the change in
statistical indices. Bayesian Information Criterion (BIC; where lower
value indicates better model fit; Nylund et al., 2007), Entropy (va-
lues> 0.80 indicating excellent accuracy; Lubke and Muthén, 2007)
and posterior probabilities of class memberships (i.e., the probability of
an individual belonging to a group; a score of 0.80 or above is pre-
ferred; Nagin, 2005) were used for decision making (see Appendix B for
statistical fit indices). Also, theoretical and clinical interpretability of
the class solutions where used when selecting the best model.
For EPDS LGMM, all the statistical indices continued to improve
and/or were satisfactory up to a 4-group model in both HCC1 and HCC2
samples (See Appendix B). The 4-group solution was also clinically
interpretable, and retained satisfactory latent group sizes, so this was
selected to model the trajectories of maternal depressive symptoms in
both samples. For SCL-90 LGMM, a 3-group solution was the best fit
with the data in HCC1 sample, whereas in the HCC2 sample 2- and 4-
group solutions appeared to fit better (see Appendix B). Statistical
analyses with both 2- and 4-class solutions were performed but as the
unadjusted associations between the group variable and HCC2 were
similar with both solutions (data not shown), the analyses were con-
tinued with the 2-class variable with larger group sizes. The group la-
beling and group sizes of the selected models are described in Figs. 2a-
d. The groups with highest overall level of PD symptoms were selected
as reference groups in pairwise comparisons.
The statistical analyses were performed using SPSS v.24 apart from




Participant sociodemographics, hair sample characteristics, and
descriptive information on the covariates, PD measurements and HCC
are described in Table 1. For all subjects (i.e the populations of both
HCC1 and HCC2 pooled together), the mean age was 30.9 (SD 4.3)
years and maternal prepregnancy BMI was 24.5 (SD 4.5) kg/m2. The
educational level of 28.1% of the mothers was elementary school,
33.6% had vocational/undergraduate education and 38.3% had an
educational degree comparable to a university degree. In all, 4.3% of
mothers in the HCC1 population had SSRI/SNRI use in early pregnancy
and 1.8% of the mothers in the HCC2 population used them in late
pregnancy.
The mean HCC was higher in HCC2 samples when compared to
HCC1 samples [20.5 (SD 19.9) pg/mg vs 19.8 (SD 34.6) pg/mg, re-
spectively; p= .002].
Both in the HCC1 and HCC2 populations, four separate subgroups
for different prenatal EPDS symptom trajectories were identified
(“Consistently low”, “Moderate and slightly increasing”, “Moderate and
steeply increasing”, and “High and decreasing” in the HCC1 sample and
“Consistently low”, “Low and increasing”, “Low and steeply in-
creasing”, and “Consistently elevated” in HCC2). Moreover, two sepa-
rate subgroups for SCL-90 symptom trajectories with HCC1 and three
for HCC2 were identified (“Consistently low” and “High and de-
creasing” in HCC1 and “Consistently low”, “Low and steeply in-
creasing”, and “High and decreasing” in HCC2). Mean levels of PD
symptoms are described for each trajectory category in Figs. 2a-d.
3.2. Associations between HCC and cross-sectional, recent PD
First, we analysed the associations between the individual PD
scores/timepoint and HCCs assessed approximately at the same time
(cross-sectional, recent PD). No associations were observed between
any type of recent PD and HCC at neither assessment point (β’s between
−0.075 and 0.12, p´s between 0.11 and 0.94; for details, see Table 2).
3.3. Associations between HCC and cumulative mean of PD
We further assessed a cumulative prevalence of symptoms com-
posing a mean score of two previous questionnaire timepoints, i.e.
mean1 and mean2 scores (cumulative mean of PD, see Table 2). HCC1
was associated with both PRAQ-R2 mean1 (β=−0.028, p= .034) and
DH1 mean1 (β=0.22, p= .013). The other measures (EPDS, SCL-90,
DH2, and DH3) were not associated with HCC1 (β´s between −0.024
and 0.016, p’s between 0.27 and 0.83; see Table 2). None of the PD
mean2 variables (EPDS, SCL-90, PRAQ-R2, DH1–3) were related to
HCC2 (β’s between −0.11 and 0.057, p’s between 0.090 and 0.97; see
Table 2), although the association between HCC2 and EPDS mean2
approached statistical significance (β=0.036, p= .090) and was thus
included in the adjusted models according to our analysis plan.
The mean1 of DH1 was associated with HCC1 also after adjusting
for all the covariates in the Models 1 and 2 (β=0.25 in both,
p’s< 0.005, see Table 3). The direction of association between PRAQ-
R2 mean1 and HCC1 was negative also in Models 1 and 2 and thus
differed from other dimensions of PD, but it did not reach statistical
significance (β´s −0.028 and −0.025, p’s 0.083 and 0.093, respec-
tively). No association was observed between EPDS mean2 and HCC2 in
the adjusted models (β’s 0.034 and 0.031, p’s 0.12 and 0.18).
3.4. Associations between HCC and trajectories of depressive and anxiety
symptoms across pregnancy
HCC2 was found to be elevated in relation to continuously higher
levels of depressive symptoms (Adj R2=0.025, p= .043, see Table 4).
In particular, the mothers in the “Consistently elevated” group pre-
sented with higher HCC than mothers in both the “Consistently low” (β
=−0.54, p= .016 for the contrast) and the “Low and increasing” (β=
−0.55, p= .026 for the contrast) groups. The associations between the
EPDS trajectories and HCC1 only approached statistical significance
(Adj R2= 0.008, p= .082) and no differences were seen in either HCC1
or HCC2 between the different SCL-90 trajectory groups (see Table 4).
The association between HCC2 and EPDS trajectories remained after
adjusting for maternal education, age and BMI in Model 1 (p value for
the EPDS trajectory variable= 0.035, for the whole model Adj
R2=0.053, p= .026; see Table 4). The association between the EPDS
trajectory variable and HCC2 was influenced by the inclusion of ma-
ternal use of SSRI/SNRI’s (Model 2) (p changing from 0.035 in Model
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1–0.065 in Model 2), but the distinct groups still predicted HCC2
[HCC2 higher in “Consistently elevated” group in comparison to
“Consistently low” (β = −0.71, p= .021) and “Low and increasing” (β
= −0.82, p= .011) groups]. Model 2 for EPDS trajectories explained
6.4% of the variance in HCC2 (p= .032). For HCC1 and EPDS trajec-
tories, no statistically significant associations were observed in the
adjusted models, although the beta estimates were similar in direction
and magnitude to those observed with EPDS and HCC2 (see Table 4).
4. Discussion
The current study aimed at examining the associations between
maternal prenatal HCC and long-term indicators of maternal prenatal
PD. According to our knowledge, this is the first study to utilize a tra-
jectory approach in modelling the course of maternal psychological
distress symptoms over time to assess the associations between HCC
and PD, either in pregnant or in non-pregnant study populations. The
results support our first a priori hypothesis that trajectories of PD across
pregnancy were associated with long-term secretion of cortisol, as the
mothers in the subgroup with the highest levels of depressive symptoms
had 3.5–4.2 % higher end-of-pregnancy HCC than the mothers in the
subgroups with low levels of overall prenatal depressive symptoms.
HCC measured at gwk 24 did not differ depending on the depression or
anxiety symptom trajectory group.
As associations with end-of-pregnancy HCC were only observed
using the trajectory-approach, that approach seems to provide novel
information on the relations between PD and long-term cortisol secre-
tion during pregnancy. The subgroup of mothers with “Low and steeply
increasing” depressive symptoms had comparably high (mean 13.8, SD
2.1) total scores on the EPDS at gwk 34, but maybe because of the lower
symptom levels in early- and mid-pregnancy, i.e. the proportionately
short time of symptom presentation, their HCC2 was not elevated. This
also supports the hypothesis that the chronicity of the prenatal symp-
toms is relevant when HPA axis functioning is investigated. In turn,
altered functioning of the HPA axis could also contribute to the per-
sistence of PD symptoms.
The trajectory approach was perhaps better-suited to be used in
comparison with HCC2 than HCC1, as the PD trajectories were assessed
from all time-points until the end of pregnancy and thus, the mid-
pregnancy HCC should have been able to predict symptoms emerging
later in time to show associations. However, it can be argued that the
HPA axis of subjects with continuously low or mid-level symptoms
would be primed to function in a different manner than that of subjects
with steeper increase or decrease in symptom prevalence.
A trajectory approach to PD symptoms has not previously been
utilized in studies with cortisol measurements but latent groups iden-
tified based on different trajectories in maternal prenatal PD have been
associated with alterations in offspring behavior. In a study by Kataja
et al. (2018), 8-month-old infants were less prone to disengage their
attention from fearful (vs. happy and neutral) faces when their mothers
belonged to groups with more chronically elevated perinatal depressive
symptoms. This supports the hypothesis that chronicity of depressive
symptoms could induce more pronounced physiological responses that
could be observed as alterations in long-term cortisol levels, and thus be
associated with offspring outcomes.
Concordant with our second hypothesis, when assessed cross-sec-
tionally with cumulative measures, associations between HCC and
prenatal PD measures were observed in mid-pregnancy but not in the
Fig. 2. (a) The mean level of maternal depressive symptoms at different time points for symptom trajectories in HCC1 population. (b). The mean level of maternal
anxiety symptoms at different time points for symptom trajectories in HCC1 population. (c). The mean level of maternal depressive symptoms at different timepoints
for symptom trajectories in HCC2 population. (d). The mean of maternal anxiety symptoms at different timepoints for symptom trajectories in HCC2 population.
Notes of abbreviation: HCC1 = hair cortisol concentration measured at gwk 24; gwk = gestational week; HCC2 = hair cortisol concentration measured 1–3 days
after delivery; EPDS = the Edinburgh Postnatal Depression Scale; SCL-90 = the Symptom Checklist−90, anxiety subscale. The populations of HCC1 (Fig. 2a and 2b)
and HCC2 (Fig. 2c and 2d) are comprised of independent samples.
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end of pregnancy as was expected based on the pregnancy-related al-
terations in HPA axis functioning. Maternal HCC was higher in mothers
who reported more worries about relationships during the first and
second trimesters and lower with more pregnancy-related anxiety. This
is in line with previous literature (Hoffman et al., 2016; Kalra et al.,
2007; Orta et al., 2018) and further supports the hypothesis that the
HPA axis would be more reactive to distress in early- and mid-preg-
nancy. This is also consistent with our third hypothesis that the type of
PD affects both whether or not associations are observed as well as the
direction of the association.
The observed negative association between pregnancy-related an-
xiety and HCC in the unadjusted models could be explained by the
general notion of anxiety disorders being associated with decreased
HCC (Stalder et al., 2017) but on the other hand, some pregnancy-
related concerns in early pregnancy may also be expected and reflect
normal adaptation. Worries about relationships and pregnancy-related
anxiety can be argued to be especially relevant during this period of
getting ready for the transition to parenthood (Huizink et al., 2017).
The characteristics of pregnancy-related anxiety are not comprehen-
sively understood but it seems to differ significantly from general an-
xiety and in some studies only pregnancy-specific anxiety was asso-
ciated with altered short-term cortisol levels (Beijers et al., 2010;
Dahlerup et al., 2018; van den Heuvel et al., 2018). In addition, in our
data these measures had more variance in symptom prevalence in
comparison to depressive or general anxiety symptoms, which could
account for the associations to be observable (see Appendix C). How-
ever, adjustment with the selected covariates led to the association
between pregnancy-related anxiety and HCC falling below the statis-
tical significance level.
Importantly, the associations observed between HCC and PD mea-
sures were generally weak. For example, worries about relationships
only accounted for 2.1% of the variance in HCC1 in the adjusted model.
The observed magnitudes of associations are not surprising as a recent
meta-analysis comprising mainly non-pregnant study populations also
reported no associations between HCC and self-reported PD when all
types of PD were reviewed pooled together (Stalder et al., 2017). As the
HPA axis reactivity alters during pregnancy, findings with large effect
sizes in pregnant populations would be surprising. Thus, our results
highlight the importance of assessing different types of PD separately
and, importantly, offer novel information on the importance of utilizing
long-term approaches in PD assessments, better paralleling with HCC
measurements. This would be important to be taken into account in
future studies despite the overall small effect sizes.
Adjusting for maternal use of SSRI/SNRI medication weakened the
associations between depressive symptoms and HCC. This is in line with
literature as there are direct effects of SSRI medication on HPA axis
functioning and most evidence suggest their use to dampen HPA axis
activity (Hinkelmann et al., 2012; Knorr et al., 2012; Ruhé et al., 2015).
Thus, the direct effects of the use of SSRI/SNRI medication could
weaken the observed positive association between HCC and depressive
symptoms. However, in our data the use of SSRI/SNRI medication was
associated with elevated HCC in mid-pregnancy. This could be due to
the subjects with continued antidepressant use during pregnancy
having more severe depressive symptoms fulfilling diagnostic criteria of
a major depressive disorder. The severity of the symptoms/disorder
could be the reason for the association with increased long-term cortisol
levels.
Variance in HCC was different for the populations with HCC1 and
HCC2 samples. It can be hypothesized that the physiological pregnancy-
related changes decrease the interindividual variance in long-term
Table 2
Correlations between HCC and cross-sectional recent and cumulative means of
prenatal PD.
HCC1 HCC2
β p N β p N
EPDS
Recenta 0.014 0.24 457 0.027 0.15 172
Cumulativeb 0.016 0.27 433 0.036† 0.090 169
SCL-90
Recenta 0.016 0.17 455 0.003 0.89 172
Cumulativeb 0.015 0.27 431 0.003 0.89 168
PRAQ-R2
Recenta 0.001 0.88 457 −0.002 0.85 172
Cumulativeb −0.028* 0.034 196 −0.006 0.65 169
Daily Hassles
Worries about relationships (DH1)
Recenta 0.12 0.11 436 −0.009 0.94 169
Cumulativeb 0.22* 0.013 399 −0.11 0.46 160
Worries about work (DH2)
Recenta 0.020 0.76 436 −0.075 0.39 169
Cumulativeb −0.024 0.73 399 0.005 0.97 160
Worries about money (DH3)
Recenta −0.022 0.72 436 0.060 0.57 169
Cumulativeb 0.015 0.83 399 0.057 0.64 160
Notes of abbreviation: PD=psyhological distress; HCC1 = hair cortisol con-
centration measured at gwk 24; gwk= gestational week; HCC2 = hair cortisol
concentration measured 1–3 days after delivery; EPDS= the Edinburgh
Postnatal Depression Scale; SCL-90 = the Symptom Checklist −90; PRAQ-R2
= the Pregnancy-related Anxiety Questionnaire -Revised2.
a total scores from single timepoints; gwk 24 questionnaires in comparison to
HCC1 and gwk 34 questionnaires in comparison to HCC2.
b mean 1 (gwk 14 and 24 questionnaires) in comparison to HCC1 and mean 2
(gwk 24 and 34 questionnaires) in comparison to HCC2.
Table 3
Adjusted models for cumulative means of prenatal PD.
UNADJUSTED MODEL 1a MODEL 2b
Adj R² β p N Adj R² β p N Adj R² β p N
PD symptom cumulative means explaining HCC1
MODEL A: Daily hassles mean1 0.009† 0.082 399 0.017† 0.083 394 0.021† 0.057 388
Worries about relationships (DH1) 0.22* 0.013 0.25** 0.005 0.25** 0.004
Worries about work (DH2) −0.024 0.73 −0.022 0.76 −0.036 0.62
Worries about money (DH3) 0.015 0.83 −0.003 0.97 0.016 0.83
MODEL B: PRAQ-R2 mean1 0.018* 0.034 195 0.024 0.13 192 0.044* 0.046 190
PRAQ-R2 −0.028* 0.034 −0.025† 0.083 −0.024† 0.093
PD symptom cumulative means explaining HCC2
MODEL C: EPDS mean2 0.011† 0.090 169 0.049* 0.045 162 0.044† 0.069 160
EPDS 0.036† 0.090 0.034 0.12 0.031 0.18
Notes of abbreviation: PD=psychological distress; HCC1 = hair cortisol concentration measured at gwk 24; gwk=gestational week; HCC2 = hair cortisol con-
centration measured 1–3 days after delivery; EPDS=the Edinburgh Postnatal Depression Scale; PRAQ-R2 = the Pregnancy-related Anxiety Questionnaire -Revised2.
a Model 1 adjusted for maternal education, maternal body mass index and maternal age.
b Model 2 adjusted for covariates in Model 1 and maternal use of SSRI/SNRI medication.
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cortisol levels towards the end of pregnancy. However, similar corre-
lations between important covariates and HCC were observed in both
HCC1 and HCC2 samples, which strengthens the reliability of the data.
In our study, 5 cm hair segments were used, thus, the possibility of
wash-out effects may not be excluded (Dettenborn et al., 2012;
Kirschbaum et al., 2009). However, as wash-out effect is not related to
prenatal PD and it has not affected the observed associations among the
first 0–6 cm (Luo et al., 2012; Steudte et al., 2011), it should not
compromise the interpretation of our data. In our data, HCC was not
associated with hair-related attributes such as hair dying or hair
washing. A sensitivity analysis adjusting for hair dying (> 70% of
subjects having their hair dyed) was also performed without any of the
main findings being significantly altered, thus we consider the factor
not to have biased the findings.
This study has several strengths. First, the relatively large number of
study subjects allowed statistical power to observe mild associations
between PD measures and HCC. Utilizing latent growth modelling as a
measure for the long-term course of PD offers a novel approach to
studying these phenomena while being easily applicable. In this study,
several types of PD were assessed in a longitudinal setting and the
measured types of distress were selected on a basis of being relevant
during the prenatal period. A wide array of potential covariates was
available for examination. In addition, HCC was measured at two dif-
ferent timepoints to assess the effects of timing on how self-reported PD
measures are reflected as alterations in HPA axis functioning.
Limitations of the study should also be considered. As the study
population comprised of a normal population with only some subjects
with higher levels of PD symptoms, the number of subjects for example
in some symptom trajectory groups was rather low. This may have
resulted in existing group differences remaining unobserved or in-
dividual values having excessive effects. Ensuring adequate group sizes
was an important factor in assessing the fits of different models that
were identified from the data and careful consideration was applied
when assessing the statistical and clinical fit of each model. The
possible influence of any outlier values was controlled by careful ex-
clusion of those subjects. Although longitudinal data was collected for
the PD measures, the two different timepoints of HCC were assessed as
two independent samples, as the number of women with both HCC
measures was too low for the purposes of this study. Longitudinal HCC
data might have given more insight into the trajectories and change in
cortisol secretion patterns in relation to the trajectories of prenatal PD.
The time spans of which the questionnaires assessed varied from one
week (EPDS) to three months (Daily Hassles) which is important to note
especially when interpreting the results of recent PD. The time spans of
cumulative means of PD correspond relatively well with the time frame
of HCC.
Relatively many subjects were excluded due to inadequate hair
sample size. This was not related to the characteristics of the study
subjects but rather to factors in the hair collection procedure and in
post hoc analysis the included and excluded subjects did not differ in
any of the PD measures or the main covariates. In line with our previous
Cohort description (Karlsson et al., 2018), the subjects with more data
available have higher educational level and are slightly older, but im-
portantly, the final study population and the whole FinnBrain Study
Cohort population did not differ in terms of the PD exposure. Not
having data on other hair steroids such as hair cortisone precluded
more detailed analyses on the HPA axis functioning and more com-
prehensive steroid profiles (Scharlau et al., 2017). The study population
was ethnically homogenous, which may limit the generalizability of the
results to multi-ethnic populations, but it also reduces effects of un-
controlled variation.
One of the main rationales in studying PD and its endocrine corre-
lates is to further understand the mechanisms by which PD can affect
fetal programming. In this study, we focus on measuring cumulative
secretion of cortisol, but it is evident that the mechanisms involved are
far more complex. Alternative pathways by which maternal PD could
affect the development of the fetus were recently reviewed by Huizink
and de Rooij (2018) and they include, for instance, mechanisms
Table 4
Adjusted models for trajectories of prenatal depressive symptoms.
UNADJUSTED MODEL 1a MODEL 2b
PD symptom trajectories explaining
HCC1
mean (SD) HCC1 (pg/
mg)
Adj R² β p N Adj R² β p N Adj R² β p N
MODEL A1: EPDS Trajectories (HCC1) 0.008† 0.082 466 0.011 0.15 442 0.016† 0.081 435
EPDS trajectory variable 0.082 0.077 0.13
Consistently low 19.12 (36.82) −0.62 0.14 315 −0.67 0.11 −0.61 0.14
Moderate and slightly increasing 20.52 (30.08) −0.41 0.33 129 −0.44 0.30 −0.40 0.34
Moderate and steeply increasing 18.89 (13.53) −0.31 0.52 16 −0.45 0.36 −0.43 0.38
High and decreasing 24.71 (16.61) ref 6 ref ref
MODEL A2: SCL trajectories (HCC1) 466
SCL-90 trajectory variable - 0.001 0.42
Consistently low 19.62 (34.96) −0.18 0.42 443
High and decreasing 18.83 (15.83) ref 23
PD symptom trajectories explaining
HCC2
mean (SD) HCC2 (pg/
mg)
Adj R² β p N Adj R² β p N Adj R² β p N
MODEL B1: EPDS Trajectories (HCC2) 0.025* 0.043 211 0.053* 0.026 200 0.064* 0.032 162
EPDS trajectory variable 0.043 0.035 0.065
Consistently low 18.62 (19.84) −0.54* 0.016 133 −0.53* 0.023 −0.71* 0.021
Low and increasing 19.52 (17.82) −0.55* 0.026 48 −0.64* 0.012 −0.82* 0.011
Low and steeply increasing 25.91 (16.46) −0.082 0.81 11 −0.064 0.86 −0.37 0.41
Consistently elevated 29.16 (25.77) ref 19 ref ref
MODEL B2: SCL trajectories (HCC2)
SCL-90 trajectory variable −0.008 0.83 211
Consistently low 19.71 (19.16) 0.17 0.59 175
Low and steeply increasing 24.70 (26.77) 0.19 0.57 25
High and decreasing 16.84 (14.30) ref 11
Notes of abbreviation: PD=psychological distress; HCC1 = hair cortisol concentration measured at gwk 24; gwk=gestational week; HCC2 = hair cortisol
concentration measured 1–3 days after delivery; EPDS= the Edinburgh Postnatal Depression Scale; SCL-90 = the Symptom Checklist −90; SSRI= selective ser-
otonin reuptake inhibitors; SNRI= serotonin-norepinephrine reuptake inhibitors.
a Model 1 adjusted for maternal education, maternal body mass index and maternal age.
b Model 2 adjusted for covariates in Model 1 and maternal use of SSRI/SNRI medication.
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concerning the maternal sympathetic nervous system (Levine et al.,
2016), neurotransmitters, especially serotonin (St-Pierre et al., 2016),
epigenetics (Cao-Lei et al., 2017), intestinal microbiome (O’Mahony
et al., 2017), immunological system (Schepanski et al., 2018), and
cognitive processes (Kataja et al., 2017).
5. Conclusions
By using modelling that illustrates long-term or cumulative ma-
ternal PD, we were able to add novel aspects to the existing literature
on how PD is related to HCC. Different types of PD seem to be differ-
entially related to HCC, albeit with generally weak associations.
However, our notion of consistently elevated depressive symptoms
being linked with end-pregnancy HCC should be further investigated, as
it appears that the prenatal symptom course is especially relevant in
comparison to short-term symptomatology. In the future HCC studies in
both pregnant and non-pregnant populations should consider the
compatibility of timelines reflected by the different measures is advised.
Longitudinal, multimodal and transgenerational studies are required to
assess the potential programming effects altered maternal long-term
cortisol levels have on offspring development.
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